Springer Knight

SpringerOpen Newsletter

Receive periodic news and updates relating to SpringerOpen.

Submit a manuscript Sign up for article alerts Contact us Support

Instructions for authors

Aim:

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.

Scope:

Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

Each article type published by Cancer Nanotechnology follows a specific format, as detailed in the corresponding instructions for authors; please choose an article type from the list on the left to view the instructions for authors.

The instructions for authors includes information about preparing a manuscript for submission to Cancer Nanotechnology, criteria for publication and the online submission process. Other relevant information about the journal's policies, the refereeing process and so on can be found in 'About this journal'.

Cancer Nanotechnology publishes the following article types:

We use plagiarism detection
CrossCheck® logo COPE logo
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

Authors and referees are asked to declare any competing interests.

Copyright rests with the authors. For more information on copyright of articles, see our publisher's copyright and license policy.